influenza
viru
iav
remain
major
threat
caus
sever
morbid
mortal
due
rapid
genom
variat
resist
iav
current
antiiav
drug
emerg
antimicrobi
peptid
amp
consid
potenti
candid
novel
treatment
iav
infect
amp
endogen
protein
play
import
role
host
defens
direct
antimicrobi
antivir
activ
immunomodulatori
effect
review
discuss
antiiav
immunomodulatori
effect
classic
amp
defensin
cathelicidin
protein
recent
discov
amplik
activ
histon
alzheim
associ
discuss
interact
amp
host
defens
protein
major
emphasi
place
novel
synthet
amp
deriv
modif
natur
protein
potenti
method
increas
express
endogen
amp
sinc
approach
may
lead
novel
antivir
therapeut
iav
present
ongo
major
threat
human
health
much
yet
learn
role
innat
immun
iav
infect
although
iav
elicit
strong
adapt
immun
respons
prone
rapid
genom
variat
either
small
increment
mutat
major
chang
result
exchang
genom
segment
anim
strain
reassort
genom
chang
allow
iav
escap
immun
respons
gener
prior
strain
gener
small
increment
chang
lead
season
epidem
wherea
reassort
lead
pandem
presenc
anim
reservoir
allow
introduct
avian
pig
strain
gene
strain
human
result
pandem
season
epidem
influenza
viru
still
contribut
tremend
morbid
mortal
includ
annual
mortal
usa
certain
group
individu
suscept
sever
outcom
season
iav
extrem
age
smoker
individu
copd
cystic
fibrosi
asthma
diabet
mellitu
cardiovascular
diseas
immun
compromis
otherwis
healthi
young
peopl
die
season
epidem
sometim
due
bacteri
superinfect
eg
note
recent
associ
iav
mrsa
pneumonia
pandem
caus
indiscrimin
mortal
young
healthi
adult
season
iav
period
day
prior
arriv
cell
lung
exposur
new
iav
strain
innat
defens
critic
time
clearli
need
therapi
iav
infect
current
two
class
antivir
drug
activ
iav
inhibitor
viral
proton
channel
protein
neuraminidas
inhibitor
high
level
resist
amantadin
emerg
resist
neuraminidas
inhibitor
report
review
evalu
potenti
antimicrobi
peptid
amp
therapi
iav
summar
vitro
vivo
antivir
immunomodulatori
activ
natur
modifi
form
peptid
iav
respiratori
tract
infect
rare
caus
viremia
direct
infect
organ
outsid
lung
despit
induc
sever
system
ill
larg
product
proinflammatori
cytokin
mortal
often
link
respiratori
failur
due
acut
lung
injuri
andor
bacteri
superinfect
addit
death
occur
due
cardiovascular
event
like
trigger
profound
inflammatori
state
result
iav
infect
vulner
subject
extens
interest
develop
antivir
iav
also
design
therapi
dampen
inflammatori
injuri
induc
viru
amp
attract
potenti
therapi
iav
sinc
antivir
antibacteri
activ
also
exert
immunomodulatori
effect
two
major
class
amphipath
amp
present
human
respiratori
line
fluid
defensin
cathelicidin
evid
class
amp
play
role
iav
infect
review
antivir
immun
modulatori
activ
defensin
cathelicidin
also
peptid
import
function
also
act
amp
eg
histon
alzheim
associ
amyloid
beta
discuss
novel
modifi
version
amp
synthes
aim
increas
antivir
activ
final
review
potenti
mean
induc
increas
product
endogen
amp
approach
antivir
treatment
two
major
class
defensin
one
group
packag
neutrophil
granul
term
human
neutrophil
peptid
hnp
hnp
like
interact
iav
vivo
sinc
neutrophil
predomin
earli
infiltr
iav
infect
airway
play
pivot
role
initi
immun
respons
viru
hnp
also
display
neutrophil
extracellular
trap
net
form
respons
iav
infect
vitro
vivo
anoth
group
express
epitheli
cell
predominantli
gut
genitourinari
tract
term
human
defensin
hd
less
reason
believ
hd
play
role
vivo
iav
infect
although
interest
strong
antivir
activ
express
predominantli
epitheli
cell
relev
particular
iav
sinc
express
respiratori
epithelium
strong
neutral
activ
mani
iav
strain
mechan
antivir
activ
hnp
fulli
elucid
found
hnp
induc
viral
aggreg
inhibit
infect
mainli
direct
interact
viru
studi
incub
epitheli
cell
defensin
preor
postinfect
minim
inhibitori
activ
direct
incub
hnp
viru
need
contrast
salvator
et
al
found
hnp
also
inhibit
iav
bind
epitheli
cell
inhibit
protein
kinas
c
addit
viral
bind
activ
defensin
potenti
format
multimolecular
assembl
defensin
may
help
account
viral
aggreg
activ
defensin
unlik
collectin
protein
bind
viral
hemagglutinin
ha
hnp
inhibit
ha
activ
iav
mice
neutrophil
antimicrobi
peptid
may
play
similar
role
henc
possibl
use
mous
model
test
role
neutrophil
human
hbd
produc
respiratori
epitheli
cell
either
constitut
respons
inflammatori
stimuli
also
inhibit
iav
hbd
less
potent
direct
inhibitor
iav
hnp
howev
may
import
immunomodulatori
role
iav
infect
well
ryan
et
al
demonstr
mice
lack
mous
defensin
sever
lung
inflamm
infect
iav
although
viral
titer
differ
compar
control
mice
paper
also
demonstr
iav
infect
increas
product
plasmacytoid
dendrit
cell
studi
vivo
contribut
iav
infect
great
interest
interest
third
class
defensin
call
retrocylin
cyclic
natur
express
primat
human
strong
antiiav
activ
retrocyclin
like
hnp
induc
aggreg
iav
appear
stronger
intrins
antivir
activ
hnp
hnp
necessari
directli
incub
viru
retrocyclin
achiev
optim
inhibit
infect
studi
evid
retrocyclin
defensin
act
lectin
bind
viral
carbohydr
may
import
contributor
activ
virus
found
promot
infect
human
immunodefici
viru
hiv
vitro
increas
viral
entri
defensin
also
counteract
antihiv
effect
polyanion
microbicid
also
report
increas
hiv
infect
facilit
transfer
viru
across
epitheli
barrier
note
studi
show
abil
defensin
inhibit
hiv
studi
indic
promot
infect
iav
defensin
distinct
group
antimicrobi
peptid
call
cathelicidin
one
repres
class
human
recent
review
discuss
extraordinari
rang
activ
includ
direct
antimicrobi
antivir
activ
chemotact
activ
variou
immun
cell
modul
macrophag
respons
inflammatori
stimuli
modul
dendrit
cell
respons
like
particip
host
respons
iav
resembl
hnp
packag
neutrophil
granul
releas
upon
cellular
activ
also
display
net
interact
iav
bind
net
like
hbd
produc
respiratori
epitheli
cell
respons
variou
stimuli
leukotrien
shown
promot
defens
iav
probabl
abil
stimul
releas
respiratori
epitheli
cell
amp
consider
literatur
antibacteri
activ
antivir
activ
recent
howev
found
inhibit
sever
virus
includ
iav
adenoviru
respiratori
syncyti
viru
hiv
sever
studi
recent
establish
role
iav
infect
barlow
et
al
first
demonstr
direct
antivir
activ
iav
contribut
host
defens
viru
vivo
limit
viral
replic
virusinduc
inflamm
also
singl
murin
cathelicidin
call
cramp
also
inhibit
iav
vitro
vivo
laboratori
report
mechan
antivir
activ
distinct
collectin
defensin
defensin
direct
incub
viru
need
caus
optim
inhibit
viral
replic
ad
cell
infect
less
effect
contrast
hnp
induc
viral
aggreg
addit
alter
viral
uptak
epitheli
cell
although
markedli
limit
subsequ
viral
replic
cell
use
electron
microscopi
evid
viral
membran
degrad
could
alter
infect
viral
intern
consist
known
membran
perturb
activ
similar
find
obtain
curri
et
al
respect
neutral
rsv
fragment
host
defens
molecul
peptid
commonli
known
serv
host
defens
function
show
amp
like
activ
regard
bacteria
virus
histon
cation
peptid
resembl
amp
regard
increas
evid
histon
serv
host
defens
role
vs
variou
organ
histon
mainli
known
abil
bind
regul
express
dna
howev
histon
also
found
cytosol
extracellular
fluid
appear
serv
function
includ
antimicrobi
activ
sever
reason
believ
histon
may
particip
immun
respons
iav
infect
like
defensin
histon
major
compon
net
addit
histon
releas
respiratori
line
fluid
varieti
lung
inflammatori
state
bulk
studi
antimicrobi
activ
histon
focus
antibacteri
activ
lysin
rich
histon
gener
found
stronger
antibacteri
activ
arginin
rich
histon
sever
studi
demonstr
antivir
activ
histon
well
recent
report
histon
abl
neutral
influenza
virus
greater
antivir
activ
antivir
effect
mediat
direct
interact
viru
rather
host
cell
addit
caus
cell
injuri
wide
rang
concentr
reduc
viral
infect
abl
strongli
aggreg
viral
particl
associ
reduc
uptak
viru
target
cell
studi
antivir
mechan
histon
warrant
peptid
mainli
known
key
role
develop
alzheim
diseas
howev
peptid
resembl
antimicrobi
peptid
amp
structur
peptid
similar
porcin
amp
protegrin
abil
form
channel
membran
structur
believ
one
antibacteri
antifung
mechan
amp
soscia
et
al
demonstr
antibacteri
antifung
activ
peptid
addit
studi
show
isol
brain
ad
patient
antimicrobi
activ
incub
brain
deriv
sampl
antibodi
ablat
antimicrobi
activ
recent
report
peptid
also
antivir
activ
iav
studi
bourgad
et
al
also
show
inhibit
herp
simplex
viru
peptid
studi
soscia
et
al
found
greater
antimicrobi
antivir
activ
demonstr
caus
viral
aggreg
appear
contribut
antivir
effect
impli
possibl
connect
abil
assembl
oligom
antivir
activ
sinc
peptid
greater
propens
form
oligom
fibril
import
recent
studi
show
peptid
exert
protect
effect
mous
worm
model
vivo
studi
demonstr
antimicrobi
mechan
peptid
involv
direct
bind
agglutin
bacteria
fungi
addit
direct
antimicrobi
antivir
effect
amp
import
modulatori
effect
respons
mani
immun
cell
see
tabl
studi
extens
abil
amp
modul
viral
interact
neutrophil
hnp
retrocyclin
histon
increas
viral
uptak
human
neutrophil
unpublish
data
obtain
similar
result
human
monocyt
unpublish
data
appear
like
abil
amp
increas
viral
uptak
link
viral
aggreg
activ
consist
interpret
alter
viral
uptak
neutrophil
amp
vari
effect
respiratori
burst
respons
neutrophil
iav
stimul
respiratori
burst
respons
character
h
product
preincub
iav
hnp
reduc
h
respons
wherea
histon
potenti
respons
also
increas
net
format
respons
iav
sever
known
receptor
phagocyt
includ
formyl
peptid
receptor
epiderm
growth
factor
receptor
receptor
use
specif
inhibitor
mean
abl
show
enhanc
h
net
respons
iav
caus
mediat
iav
potent
stimul
neutrophil
product
monocyt
macrophag
proinflammatori
cytokin
product
eg
tnf
proinflammatori
cytokin
product
vivo
correl
symptomatolog
lung
injuri
caus
iav
major
goal
current
iav
research
reduc
inflammatori
effect
viru
reduc
lung
injuri
mous
model
lung
injuri
reduc
even
viral
load
unaffect
case
report
reduc
cytokin
respons
variou
stimuli
inde
found
reduc
neutrophil
respons
iav
lp
process
studi
effect
variou
amp
monocyt
macrophag
cytokin
respons
iav
note
treatment
mice
infect
iav
reduc
cytokin
respons
effect
appear
part
independ
reduct
viral
load
vivo
hnp
releas
die
neutrophil
shown
mediat
antiinflammatori
effect
addit
hnp
taken
macrophag
bacteri
infect
inhibit
macrophag
inflammatori
cytokin
product
restrict
protein
translat
relev
find
iav
infect
evalu
thu
far
note
also
delet
result
greater
inflammatori
reaction
iav
despit
chang
viral
titer
hbd
shown
strong
antiinflammatori
effect
well
lp
model
interest
test
peptid
context
iav
infect
even
though
extens
studi
proinflammatori
stimulu
found
reduc
inflammatori
cytokin
product
trigger
iav
monocyt
vitro
overal
result
indic
maxim
antiinflammatori
effect
well
antivir
activ
consid
design
novel
amp
treatment
iav
contrast
perspect
arisen
sever
studi
increas
inflamm
prior
iav
sarscov
infect
protect
studi
wohlfordlenan
et
al
intranas
instil
retrocyclin
alon
induc
lung
inflamm
associ
protect
vs
sarscov
anoth
studi
direct
instil
hnp
airway
mice
proinflammatori
effect
independ
infect
note
model
list
hnp
antiinflammatori
effect
henc
studi
need
determin
best
administ
amp
vivo
whether
possibl
proinflammatori
effect
would
harm
benefici
respect
infect
although
histon
antimicrobi
antivir
activ
consid
instig
sever
system
inflammatori
diseas
tissu
injuri
includ
sepsi
periton
pancreat
stroke
acut
lung
injuri
liver
injuri
kidney
injuri
inject
histon
mice
stimul
proinflammatori
cytokinechemokin
releas
eg
tnf
leukocyt
infiltr
result
sepsislik
patholog
case
histon
function
damageassoci
molecular
pattern
molecul
possibl
mechan
induc
cytokin
storm
may
interact
tolllik
receptor
tlr
especi
inflammasom
know
possibl
detriment
proinflammatori
effect
histon
studi
need
investig
role
histon
sever
iav
iavrel
lung
injuri
amp
term
alarmin
abl
trigger
recruit
activ
immun
cell
amp
modul
adapt
immun
respons
variou
way
topic
beyond
scope
paper
howev
refer
reader
review
exampl
hbd
defensin
bind
receptor
lymphocyt
act
chemoattract
facilit
present
antigen
dc
cell
shown
potenti
neutral
antibodi
respons
enter
viral
infect
contribut
activ
iav
infect
studi
certainli
valuabl
area
futur
research
bacteri
superinfect
major
contributor
mortal
pandem
season
epidem
iav
bacteri
superinfect
difficult
treat
antibiot
result
great
interest
identifi
caus
bacteri
superinfect
interven
prevent
treat
infect
role
amp
bacteri
superinfect
possibl
treatment
bacteri
superinfect
studi
howev
given
combin
antivir
antibacteri
activ
mani
amp
attract
candid
treatment
combin
iav
bacteri
infect
like
activ
amp
vivo
reflect
complex
interact
among
variou
amp
host
defens
molecul
found
hnp
bind
lung
host
defens
surfact
regulatori
protein
surfact
protein
spd
import
bind
vivo
clear
howev
hnp
inhibit
antivir
activ
spd
caus
precipit
spd
human
bal
fluid
sinc
spd
antiinflammatori
properti
uninfect
infect
lung
properti
hnp
could
account
inflammatori
respons
seen
upon
instil
hnp
lung
hand
spd
might
aid
clearanc
hnp
neutrophil
infiltr
note
found
hbd
bind
spd
may
advantag
consid
use
peptid
therapi
lung
retrocyclin
addit
antivir
effect
combin
spd
histon
consid
augment
inflammatori
respons
promot
thrombosi
thu
respons
iavrel
acut
lung
injuri
note
evid
host
defens
protein
bind
histon
modul
potenti
advers
effect
littl
known
relationship
histon
spd
evid
suggest
spd
simultan
bind
pathogen
net
recent
found
spd
bind
histon
inhibit
histoneinduc
respiratori
burst
neutrophil
unpublish
data
creactiv
protein
crp
acut
phase
reactant
anoth
host
defens
protein
usual
elev
infect
inflamm
crp
treatment
mice
found
allevi
histoneinduc
toxic
includ
endotheli
damag
thrombosi
lung
edema
protein
like
thrombomodulin
similar
effect
find
suggest
possibl
modul
histon
studi
need
extens
research
way
modifi
mimic
structur
defensin
order
improv
antibacteri
antivir
activ
result
studi
summar
tabl
even
singl
amino
acid
substitut
potenti
antivir
activ
instanc
replac
singl
arginin
lysin
retrocyclin
result
increas
bind
inhibit
hiv
modifi
retrocyclin
also
increas
iav
neutral
activ
similarli
replac
singl
amino
acid
result
increas
activ
vs
hsv
strong
activ
retrocyclin
also
inspir
construct
panel
cyclic
peptid
ruchala
lehrer
intent
retain
improv
antivir
activ
natur
occur
retrocyclin
cyclic
peptid
easier
synthes
peptid
term
hapivirin
diprovirin
incorpor
systemat
substitut
key
cation
hydrophob
residu
also
incorpor
sever
synthet
amino
acid
sever
hapivirin
diprovirin
markedli
increas
neutral
activ
iav
addit
peptid
retain
properti
viral
aggreg
increas
viral
uptak
neutrophil
like
retrocyclin
interfer
viral
neutral
activ
spd
case
hapivirin
substitut
increas
hydrophob
caus
clear
increas
antivir
activ
indic
hydrophob
import
featur
cation
charg
antivir
activ
activ
hapivirin
diprovirin
also
strong
abil
suppress
tnf
gener
human
monocyt
recent
paper
zhao
et
al
took
approach
prepar
seri
fragment
mous
beta
defensin
test
activ
panel
clinic
import
respiratori
virus
includ
human
avian
iav
strain
sarscov
merscov
amino
acid
fragment
term
author
found
activ
exceed
full
amino
acid
protein
vitro
vivo
mice
fact
mice
surviv
lethal
challeng
mous
adapt
viral
strain
pretreat
intranas
peptid
also
reduc
lung
inflamm
viral
load
mice
also
increas
surviv
mice
infect
lethal
dose
avian
vitro
antivir
activ
sarscov
merscov
respiratori
viral
strain
great
concern
due
pandem
potenti
sever
outcom
infect
human
mechan
action
found
includ
bind
iav
enter
cell
along
viru
impair
endosom
acidif
henc
viral
escap
endosom
studi
provid
interest
exampl
shorten
fragment
natur
occur
defensin
greater
activ
parent
peptid
similar
vein
shorten
subtli
modifi
version
test
antivir
antibacteri
activ
amino
acid
fragment
term
found
retain
antivir
activ
full
molecul
season
iav
hiv
anoth
fragment
call
activ
iav
despit
fact
inhibit
hiv
antibacteri
activ
well
two
ntermin
fragment
antibacteri
activ
fail
inhibit
iav
fragment
incorpor
central
helix
differ
one
amino
acid
sequenc
isoleucin
chang
glycin
note
pandem
inhibit
vitro
peptid
provid
anoth
exampl
shorten
version
natur
amp
increas
antivir
activ
compar
parent
peptid
also
retain
abil
increas
neutrophil
respiratori
burst
net
respons
iav
also
suppress
neutrophil
respons
viru
abil
increas
viru
induc
respiratori
burst
net
respons
also
mediat
bind
use
molecular
model
found
incorpor
domain
protein
predict
bind
receptor
lactoferrin
evolutionarili
conserv
innat
immun
protein
present
breast
milk
mucos
secret
cation
activ
bacteria
sever
virus
includ
iav
lactoferrin
two
lobe
n
c
lobe
contain
iron
bind
site
although
n
c
lobe
similar
structur
distinct
sequenc
within
two
lobe
separ
proteolyt
cleavag
shown
distinct
function
activ
recent
studi
ammendolia
et
al
show
antiinfluenza
activ
bovin
lactoferrin
c
lobe
shorter
peptid
domain
within
c
lobe
picomolar
activ
iav
peptid
greater
antivir
activ
vitro
greater
select
indic
measur
combin
antivir
activ
cellular
cytotox
whole
lactoferrin
protein
antivir
activ
lactoferrin
relat
bind
ha
subunit
viral
hemagglutinin
contain
fusion
domain
amino
acid
ntermin
fragment
human
bpi
recent
shown
inhibit
variou
iav
strain
includ
strain
vitro
direct
action
viru
interest
murin
homolog
peptid
lack
antiiav
activ
addit
human
peptid
inhibit
tnf
respons
monocyt
trigger
iav
mechan
resist
amp
well
describ
bacteria
howev
similar
data
virus
note
found
pandem
iav
inhibit
although
fragment
inhibitori
similarli
found
murin
cathelicidin
cramp
human
histon
inhibit
pandem
reduc
activ
pandem
strain
well
mechan
resist
pandem
strain
clear
sinc
amp
activ
season
mous
adapt
strain
iav
use
revers
genet
viral
strain
prepar
ha
pandem
strain
gene
segment
season
strain
reassort
strain
sensit
cramp
histon
indic
resist
mediat
hemagglutinin
pandem
strain
studi
import
determin
compon
pandem
strain
confer
resist
sever
amp
one
challeng
featur
develop
amp
therapeut
determin
administ
note
evid
direct
administr
airway
may
induc
inflammatori
respons
anoth
approach
explor
increas
endogen
product
amp
variou
mean
result
studi
summar
tabl
note
potenti
gener
hbd
respiratori
tract
gener
epitheli
cell
regul
vitamin
henc
replet
vitamin
may
host
defens
benefit
gener
also
enhanc
histon
deacetylas
inhibitor
eg
phenylbutyr
approach
found
improv
outcom
ad
standard
antibiot
treatment
mycobacterium
tuberculosi
infect
human
interest
report
also
show
supplement
amino
acid
isoleucin
increas
hbd
express
studi
phenomenon
special
interest
given
low
toxic
approach
shown
induc
express
hbd
peptid
anoth
group
amp
human
keratinocyt
one
paper
report
endogen
gener
retrocyclin
human
cell
exposur
aminoglycosid
antibiot
human
cell
actual
contain
gene
retrocyclin
express
due
prematur
stop
codon
signal
sequenc
clearli
studi
amp
induct
infanc
howev
sever
tantal
find
certainli
support
explor
approach
iav
caus
mani
death
sever
ill
everi
year
season
outbreak
potenti
caus
massiv
morbid
mortal
pandem
resist
two
class
drug
current
use
iav
treatment
emerg
extens
interest
develop
new
antivir
treatment
viru
death
caus
iav
infect
mostli
result
acut
lung
injuri
system
inflamm
bacteri
superinfect
suggest
new
treatment
antivir
antibacteri
antiinflamm
effect
would
ideal
amp
antimicrobi
peptid
play
import
role
host
defens
pathogen
also
modul
inflammatori
respons
thu
potenti
candid
iav
treatment
discuss
interact
two
class
classic
amp
defensin
cathelicidin
two
nonclass
amp
histon
iav
paper
part
amp
possess
antiiav
activ
direct
interact
viru
although
instanc
direct
interact
mammalian
cell
may
contribut
antivir
effect
amp
discuss
also
immunomodulatori
effect
upregul
other
downregul
inflamm
provid
exampl
eg
hapivirin
diprovirin
novel
synthet
amp
amp
fragment
improv
antiiav
immunomodulatori
activ
suggest
modif
amp
attract
strategi
studi
requir
determin
interact
amp
host
defens
protein
lung
best
method
administ
induc
gener
amp
explain
instanc
resist
pandem
iav
strain
amp
